Dabrafenib and Trametinib Treatment for Erdheim-Chester Disease With Brain Stem Involvement.

Al Bayati, Ahmed; Plate, Thomas; Al Bayati, Mahmood; Yan, Yaohong; Lavi, Efrat Saraf; Rosenblatt, Joseph D

Al Bayati, Ahmed; Plate, Thomas; Al Bayati, Mahmood; Yan, Yaohong; Lavi, Efrat Saraf; Rosenblatt, Joseph D.

Afiliación

Al Bayati A; Department of Hematology and Oncology, University of Miami Miller School of Medicine, Miami, FL.
Plate T; Department of Hematology and Oncology, University of Miami Miller School of Medicine, Miami, FL.
Al Bayati M; Department of Hematology and Oncology, University of Miami Miller School of Medicine, Miami, FL.
Yan Y; Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL.
Lavi ES; Department of Radiology, University of Miami Miller School of Medicine, Miami, FL.
Rosenblatt JD; Department of Hematology and Oncology, University of Miami Miller School of Medicine, Miami, FL.

Mayo Clin Proc Innov Qual Outcomes ; 2(3): 303-308, 2018 Sep.

Article en En | MEDLINE | ID: mdl-30225465

Palabras clave

CNS, central nervous system; CSF, cerebrospinal fluid; ECD, Erdheim-Chester disease; FDA, Food and Drug Administration; IFN-α, interferon alfa; MRI, magnetic resonance imaging; PET/CT, positron emission tomography/computed tomography

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Mayo Clin Proc Innov Qual Outcomes Año: 2018 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google